Brain Metastases
📧 Sign up to get email alerts when something new happens for Brain Metastases.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Genetic Testing in Guiding Treatment for Patients With Brain Metastases [Phase 2]
Phase 2 study evaluating whether genetic testing can guide treatment for patients with brain metastases; the trial is currently active but n…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: SRS Compared With FSRS for Treatment of Intact Metastatic Brain Disease, FRACTIONATE Trial [Phase 2]
A Phase 2 FRACTIONATE trial compares single-session stereotactic radiosurgery (SRS) with fractionated SRS (FSRS) for intact brain metastases…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: SMART Trial: Cognitive Sparing Brain Radiotherapy for Multiple Brain Metastases [Phase 2]
The SMART trial is evaluating cognitive-sparing brain radiotherapy for patients with multiple brain metastases in solid tumors. The Phase 2 …
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: A Phase II Study of Nivolumab With Ipilimumab and Cabozantinib in Patients With Untreated Renal Cell Carcinoma Brain Metastases [Phase 2]
This clinical trial update outlines a Phase II study of nivolumab with ipilimumab and cabozantinib in patients with untreated renal cell car…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Nitroglycerin Plus Radiotherapy Versus Conventional Radiotherapy in Patients With Lung Cancer. [NA]
A clinical trial is evaluating nitroglycerin as a radiosensitizer added to radiotherapy versus conventional radiotherapy in patients with no…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Delayed or Upfront Brain RAdiotherapy in Treatment naïve Lung Cancer Patients With Asymptomatic or Minimally Symptomatic Brain Metastases and ALK rEarrangements [Phase 1, Phase 2]
A phase 1/2 clinical trial is investigating optimal timing of brain radiotherapy (delayed vs upfront) in treatment‑naïve non-small cell lung…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Memory Avoidance Whole Brain Radiotherapy vs Hippocampal Avoidance Whole Brain Radiotherapy (Athena 2 Trial) [Phase 2]
Clinical trial comparing memory-avoidant whole-brain radiotherapy with hippocampal-avoidant whole-brain radiotherapy in patients with brain …
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Trial to Study Anti- HCMV Therapy in Breast Cancer Patients With Progressive Intracranial Metastases and CMV Infection [Phase 2]
A Phase 2 clinical trial update for anti-CMV therapy in breast cancer patients with progressive intracranial metastases and CMV infection, c…
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Pilot Study of Nivolumab w/Ipilimumab or Relatlimab in Surgically Resectable Melanoma Brain Metastases [EARLY_Phase 1]
A Phase 1 pilot trial evaluating nivolumab plus either ipilimumab or relatlimab for surgically resectable melanoma with brain metastases has…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Bevacizumab Plus FSRT Versus Hippocampus-Avoidant WBRT in Lung Adenocarcinoma With Extensive Brain Metastases [Phase 3]
Phase 3 clinical trial investigating bevacizumab plus fractionated stereotactic radiotherapy (FSRT) versus hippocampus-avoidant whole-brain …
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer [Phase 1, Phase 2]
This clinical trial update indicates a Phase 1/2 study evaluating the combination of abemaciclib and elacestrant in participants with ER+/HE…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Comparing Single vs Multiple Dose Radiation for Cancer Patients With Brain Metastasis and Receiving Immunotherapy [NA]
A clinical trial update comparing single-dose versus multiple-dose radiation in cancer patients with brain metastases who are receiving immu…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain [Phase 3]
Phase 3 trial comparing longer-duration radiation therapy versus standard radiation therapy for patients with cancer that has spread to the …
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Comparing the Addition of Radiation Either Before or After Surgery for Patients With Brain Metastases [Phase 3]
Phase 3 clinical trial evaluating whether radiation should be given before versus after surgery for brain metastases; the study is currently…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Study of SHR-A1811 in HER2-expression Advanced Breast Cancer With Brain Metastases [Phase 2]
Phase 2 clinical trial evaluating SHR-A1811 in HER2-positive metastatic breast cancer with brain metastases; recruitment is ongoing. The stu…
-
CLINICAL_TRIALS trial_result · 2026-04-01Clinical Trial Update: A Phase II Clinical Study of Utidelone and Bevacizumab With or Without Etoposide in Patients With Brain Metastases From Malignant Solid Tumors [Phase 2]
A Phase II clinical study evaluating Utidelone and Bevacizumab, with or without Etoposide, in patients with brain metastases from malignant …
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Targeted Pediatric High-Grade Glioma Therapy
A pediatric clinical trial is currently recruiting to evaluate a targeted therapy for high-grade gliomas, including diffuse intrinsic pontin…
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: Detection and Metabolic Characterization in DOPA PET/CT of Brain Metastases [NA]
Completed clinical trial examining detection and metabolic characterization of brain metastases using DOPA PET/CT.
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Contribution of the CEST Sequence in the Characterization of Radionecrosis of Brain Metastases of Pulmonary Origin [NA]
A clinical trial evaluating the CEST MRI sequence for characterizing radionecrosis in brain metastases originating from lung cancer; current…
-
CLINICAL_TRIALS withdrawal · 2026-03-31Clinical Trial Update: Phase Ib/II Trial of Abemaciclib and Elacestrant in Patients With Brain Metastasis Due to HR+/Her2- Breast Cancer [Phase 1, Phase 2]
A Phase Ib/II study of Abemaciclib plus Elacestrant for brain metastases stemming from HR+/HER2- breast cancer was terminated.
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Preop fSRS for Resectable Brain Metastases [Phase 2]
Phase 2 trial investigating preoperative fractionated stereotactic radiosurgery for resectable brain metastases; trial status is active but …
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Neuropsychological Changes in Patients Receiving Radiation Therapy for Brain Metastases
The document reports on a completed clinical trial studying neuropsychological changes in patients with brain metastases treated with radiat…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating pembrolizumab in combination with stereotactic radiosurgery for selected brain metastases in patien…
-
CLINICAL_TRIALS other · 2026-03-30Clinical Trial Update: WSD0922-FU for the Treatment of Glioblastoma, Anaplastic Astrocytoma, or Non-small Cell Lung Cancer With Central Nervous System Metastases [Phase 1]
Phase 1 clinical trial update for WSD0922-FU evaluating safety and preliminary activity in glioblastoma, anaplastic astrocytoma, and non-sma…
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Osimertinib Combined With Intracranial SRT for EGFR-Mutant NSCLC With Symptomatic Brain Metastases
An ongoing clinical trial is evaluating osimertinib in combination with intracranial stereotactic radiotherapy for EGFR-mutant non-small cel…